These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 24013001

  • 1. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M, Corsa AC, Xu S, Peng B, Gong R, Lee YJ, Chan K, Mo H, Delaney W, Cheng G.
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [Abstract] [Full Text] [Related]

  • 2. Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a.
    Robinson M, Yang H, Sun SC, Peng B, Tian Y, Pagratis N, Greenstein AE, Delaney WE.
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3099-106. PubMed ID: 20516274
    [Abstract] [Full Text] [Related]

  • 3. Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
    Yu M, Peng B, Chan K, Gong R, Yang H, Delaney W, Cheng G.
    Antimicrob Agents Chemother; 2014 May; 58(5):2638-46. PubMed ID: 24550344
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.
    Wose Kinge CN, Espiritu C, Prabdial-Sing N, Sithebe NP, Saeed M, Rice CM.
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5386-94. PubMed ID: 24982066
    [Abstract] [Full Text] [Related]

  • 5. Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
    Camus G, Xu S, Han B, Lu J, Dvory-Sobol H, Yu M, Cheng G, Miller MD, Doehle BP, Mo H.
    Virology; 2018 Jan 15; 514():134-141. PubMed ID: 29175627
    [Abstract] [Full Text] [Related]

  • 6. Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells.
    Liang C, Rieder E, Hahm B, Jang SK, Paul A, Wimmer E.
    Virology; 2005 Mar 01; 333(1):41-53. PubMed ID: 15708591
    [Abstract] [Full Text] [Related]

  • 7. Screening of hepatitis C virus inhibitors using genotype 1a HCV replicon cell lines.
    Robinson M, Tian Y, Pagratis N, Delaney WE.
    Curr Protoc Microbiol; 2011 Aug 01; Chapter 17():Unit17.7. PubMed ID: 21805689
    [Abstract] [Full Text] [Related]

  • 8. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
    Chan K, Robinson M, Yang H, Cornew S, Delaney Iv WE.
    Antiviral Res; 2013 Apr 01; 98(1):85-92. PubMed ID: 23376631
    [Abstract] [Full Text] [Related]

  • 9. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication.
    Sahuc ME, Sahli R, Rivière C, Pène V, Lavie M, Vandeputte A, Brodin P, Rosenberg AR, Dubuisson J, Ksouri R, Rouillé Y, Sahpaz S, Séron K.
    J Virol; 2019 May 15; 93(10):. PubMed ID: 30842319
    [Abstract] [Full Text] [Related]

  • 10. In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir.
    Ng TI, Tripathi R, Reisch T, Lu L, Middleton T, Hopkins TA, Pithawalla R, Irvin M, Dekhtyar T, Krishnan P, Schnell G, Beyer J, McDaniel KF, Ma J, Wang G, Jiang LJ, Or YS, Kempf D, Pilot-Matias T, Collins C.
    Antimicrob Agents Chemother; 2018 Jan 15; 62(1):. PubMed ID: 29084747
    [Abstract] [Full Text] [Related]

  • 11. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R, Holmbeck K, Nielsen L, Kapoor A, Rice CM, Bukh J, Scheel TKH.
    J Virol; 2019 Oct 01; 93(19):. PubMed ID: 31292246
    [Abstract] [Full Text] [Related]

  • 12. A cellular replicon-based phenotyping assay to determine susceptibility of hepatitis C virus clinical isolates to NS3/4A protease inhibitors.
    Vijgen L, Verbeeck J, Van Kerckhove B, Berke JM, Koletzki D, Fanning G, Lenz O.
    Methods Mol Biol; 2013 Oct 01; 1030():105-17. PubMed ID: 23821263
    [Abstract] [Full Text] [Related]

  • 13. Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
    Saeed M, Scheel TK, Gottwein JM, Marukian S, Dustin LB, Bukh J, Rice CM.
    Antimicrob Agents Chemother; 2012 Oct 01; 56(10):5365-73. PubMed ID: 22869572
    [Abstract] [Full Text] [Related]

  • 14. Development of hepatitis C virus chimeric replicons for identifying broad spectrum NS3 protease inhibitors.
    Binder J, Tetangco S, Weinshank M, Maegley K, Lingardo L, Diehl W, Love R, Patick AK, Smith GJ.
    Antiviral Res; 2011 Aug 01; 91(2):102-11. PubMed ID: 21620899
    [Abstract] [Full Text] [Related]

  • 15. Development and characterization of a replicon-based phenotypic assay for assessing HCV NS4B from clinical isolates.
    Rajyaguru S, Yang H, Martin R, Miller MD, Mo H.
    Antiviral Res; 2013 Nov 01; 100(2):328-36. PubMed ID: 24013002
    [Abstract] [Full Text] [Related]

  • 16. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
    Hao W, Herlihy KJ, Zhang NJ, Fuhrman SA, Doan C, Patick AK, Duggal R.
    Antimicrob Agents Chemother; 2007 Jan 01; 51(1):95-102. PubMed ID: 17060518
    [Abstract] [Full Text] [Related]

  • 17. Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates.
    Qi X, Bae A, Liu S, Yang H, Sun SC, Harris J, Delaney W, Miller M, Mo H.
    Antiviral Res; 2009 Feb 01; 81(2):166-73. PubMed ID: 19063924
    [Abstract] [Full Text] [Related]

  • 18. A serine palmitoyltransferase inhibitor blocks hepatitis C virus replication in human hepatocytes.
    Katsume A, Tokunaga Y, Hirata Y, Munakata T, Saito M, Hayashi H, Okamoto K, Ohmori Y, Kusanagi I, Fujiwara S, Tsukuda T, Aoki Y, Klumpp K, Tsukiyama-Kohara K, El-Gohary A, Sudoh M, Kohara M.
    Gastroenterology; 2013 Oct 01; 145(4):865-73. PubMed ID: 23791700
    [Abstract] [Full Text] [Related]

  • 19. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N, Bellows D, Ansari I, Lai VC, Dempsey S, Liang D, Donis R, Zhong W, Hong Z.
    J Virol; 2005 Mar 01; 79(5):2788-96. PubMed ID: 15708997
    [Abstract] [Full Text] [Related]

  • 20. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
    Chen M, Xu Y, Li N, Yin P, Zhou Q, Feng S, Wu T, Wei L, Wang H, Fu Y, Li YP.
    J Gen Virol; 2021 Dec 01; 102(12):. PubMed ID: 34949310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.